Dr. John Zarosky, MD
NPI: 1568626646
Total Payments
$2,928
2024 Payments
$611.36
Companies
36
Transactions
187
Medicare Patients
914
Medicare Billing
$84,958
Payment Breakdown by Category
Food & Beverage$2,922 (99.8%)
Education$5.90 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,922 | 186 | 99.8% |
| Education | $5.90 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $362.21 | 22 | $0 (2024) |
| ABBVIE INC. | $259.14 | 18 | $0 (2024) |
| Amarin Pharma Inc. | $229.21 | 13 | $0 (2022) |
| GlaxoSmithKline, LLC. | $201.49 | 11 | $0 (2024) |
| Abbott Laboratories | $193.64 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $181.81 | 14 | $0 (2024) |
| Lilly USA, LLC | $171.47 | 12 | $0 (2024) |
| PFIZER INC. | $146.05 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $124.73 | 8 | $0 (2024) |
| Novo Nordisk Inc | $114.99 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $611.36 | 36 | Novo Nordisk Inc ($72.78) |
| 2023 | $521.75 | 30 | PFIZER INC. ($74.44) |
| 2022 | $609.79 | 36 | Boehringer Ingelheim Pharmaceuticals, Inc. ($145.81) |
| 2021 | $228.71 | 14 | Biohaven Pharmaceuticals, Inc. ($30.62) |
| 2020 | $150.58 | 11 | AstraZeneca Pharmaceuticals LP ($37.29) |
| 2019 | $490.39 | 35 | Amarin Pharma Inc. ($137.11) |
| 2018 | $303.34 | 24 | Amgen Inc. ($37.29) |
| 2017 | $11.62 | 1 | Valeant Pharmaceuticals North America LLC ($11.62) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 2 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Diabetes | ||||||
| 03/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Endocrinology | ||||||
| 02/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardiology | ||||||
| 02/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Inflammation | ||||||
| 02/20/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Biological | ||||||
| 02/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: DIABETES | ||||||
| 01/31/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes Care | ||||||
| 01/25/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: PAIN | ||||||
| 01/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 12/14/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Cardio-renal | ||||||
| 11/30/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Diabetes Care | ||||||
| 11/28/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: EndoVenous Therapies | ||||||
| 11/20/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Analgesic | ||||||
| 11/16/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Diabetes | ||||||
| 11/03/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: PAIN | ||||||
| 10/26/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $17.75 | General |
| Category: PSYCHOLOGY | ||||||
| 10/24/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Biological | ||||||
| 10/17/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 08/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 244 | 402 | $108,106 | $25,686 |
| 2022 | 6 | 251 | 382 | $93,562 | $22,566 |
| 2021 | 4 | 216 | 353 | $90,579 | $20,990 |
| 2020 | 5 | 203 | 302 | $77,750 | $15,716 |
Total Patients
914
Total Services
1,439
Medicare Billing
$84,958
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 261 | $84,303 | $18,885 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 76 | $16,568 | $4,420 | 26.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $5,085 | $1,905 | 37.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 32 | 50 | $2,150 | $476.00 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 212 | $68,476 | $15,387 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 68 | $14,824 | $4,016 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $3,729 | $1,434 | 38.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 21 | 25 | $3,275 | $895.03 | 27.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 34 | 54 | $2,322 | $507.82 | 21.9% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 12 | 12 | $936.00 | $326.03 | 34.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 218 | $70,414 | $15,854 | 22.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 50 | 72 | $15,696 | $4,008 | 25.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 20 | $2,620 | $720.80 | 27.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 26 | 43 | $1,849 | $407.82 | 22.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 166 | $53,618 | $10,506 | 19.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 99 | $21,582 | $4,121 | 19.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $990.00 | $670.78 | 67.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 15 | 15 | $900.00 | $234.36 | 26.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $660.00 | $184.14 | 27.9% |
About Dr. John Zarosky, MD
Dr. John Zarosky, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1568626646.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Zarosky, MD has received a total of $2,928 in payments from pharmaceutical and medical device companies, with $611.36 received in 2024. These payments were reported across 187 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($2,922).
As a Medicare-enrolled provider, Zarosky has provided services to 914 Medicare beneficiaries, totaling 1,439 services with total Medicare billing of $84,958. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine, Sports Medicine
- Location Bedford, TX
- Active Since 07/17/2008
- Last Updated 05/20/2013
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1568626646
Products in Payments
- NURTEC ODT (Drug) $269.78
- JARDIANCE (Drug) $259.23
- Vascepa (Drug) $229.21
- UBRELVY (Drug) $127.99
- FARXIGA (Drug) $124.94
- MOUNJARO (Drug) $124.44
- FREESTYLE LIBRE 3 (Device) $108.97
- TRELEGY ELLIPTA (Drug) $106.61
- Kerendia (Drug) $88.04
- Ozempic (Drug) $67.71
- VRAYLAR (Drug) $65.97
- FREESTYLE LIBRE 2 (Device) $61.73
- Myrbetriq (Drug) $58.63
- JANUVIA (Drug) $58.62
- STIOLTO RESPIMAT (Drug) $50.94
- QULIPTA (Drug) $48.24
- Veozah (Drug) $46.74
- SHINGRIX (Biological) $45.67
- SPIRIVA RESPIMAT (Drug) $45.32
- Dexcom G6 Transmitter (Medical Supply) $45.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Bedford
Dr. Alexander Gamble, Do, DO
Student in an Organized Health Care Education/Training Program — Payments: $21,600
Student in an Organized Health Care Education/Training Program $21,600
Seung Yeon Bae
Student in an Organized Health Care Education/Training Program — Payments: $1,461
Student in an Organized Health Care Education/Training Program $1,461
Dr. Raulee Morello, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $424.50
Student in an Organized Health Care Education/Training Program $424.50
Mrs. Ami Patel-Yadav, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $389.18
Student in an Organized Health Care Education/Training Program $389.18
Dr. Laura Jones, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $351.17
Student in an Organized Health Care Education/Training Program $351.17
Dr. Pooja Amirneni, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $296.43
Student in an Organized Health Care Education/Training Program $296.43